Risk factor
Negligible price volatility
Profitability factor
Very strong margins and returns
About
Bumrungrad Hospital Public Company Limited functions as a leading healthcare provider, overseeing a network of medical facilities operating both domestically in Thailand and internationally. Its medical centers offer a full range of services, including sophisticated diagnostic procedures, diverse therapeutic treatments, and critical intensive care. The company boasts a broad spectrum of specialized outpatient clinics, numbering around 56, which cater to an extensive array of medical needs from allergy and cardiology to cancer care, women's health, and rehabilitation. This includes specialized centers for behavioral health, dental services, diabetes management, emergency care, fertility, health screening, neurosciences, orthopedics, plastic surgery, and sports medicine, among numerous other specialties. Beyond direct patient care, Bumrungrad is also involved in managing real estate assets, conducting clinical research, distributing pharmaceuticals and medical supplies, operating a dedicated training and development center for healthcare professionals, and providing patient referral services. Founded in 1980 and based in Bangkok, Thailand, the company maintains a significant operational footprint, featuring 580 hospital beds.
Company Valuation
From both historical and forecast perspectives, the stock is considerably overpriced compared to similar stocks. In particular, the stock is reasonably priced on P/E, of
Target Price
The average target price of BH.BK is 208 and suggests 5.38% upside potential. Usually, this means a HOLD recommendation among investment firms. This neutral recommendatio